Rathbones Group PLC Gilead Sciences, Inc. Transaction History

Rathbones Group PLC

$17.8 Billion
Q2 2024

A detailed history of Rathbones Group PLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Rathbones Group PLC holds 3,270 shares of GILD stock, worth $288,708. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,270

Previous 3,692 11.43%

Holding current value

$288,708

Previous $270,000 17.04%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$63.15 - $72.88 $26,649 - $30,755	-422 Reduced 11.43%	3,270 $224,000
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $35,288 - $43,033	-493 Reduced 11.78%	3,692 $270,000
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $10,990 - $12,463	150 Added 3.72%	4,185 $339,000
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $298,347 - $325,503	4,035 New	4,035 $302,000
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $60,894 - $68,585	-1,055 Reduced 19.45%	4,369 $270,000
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $54,953 - $62,373	-847 Reduced 13.51%	5,424 $394,000
Q3 2021 Nov 04, 2021	SELL	$67.69 - $73.03 $177,753 - $191,776	-2,626 Reduced 29.52%	6,271 $438,000
Q2 2021 Jul 30, 2021	BUY	$63.47 - $69.35 $8,187 - $8,946	129 Added 1.47%	8,897 $613,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $57,000 - $65,036	-950 Reduced 9.78%	8,768 $567,000
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $7,761 - $8,843	-137 Reduced 1.39%	9,718 $566,000
Q2 2020 Aug 07, 2020	BUY	$72.34 - $84.0 $72,629 - $84,336	1,004 Added 11.34%	9,855 $758,000
Q1 2020 May 04, 2020	BUY	$62.63 - $80.22 $122,504 - $156,910	1,956 Added 28.37%	8,851 $662,000
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $21,567 - $23,723	-350 Reduced 4.83%	6,895 $448,000
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $73,449 - $81,075	1,175 Added 19.36%	7,245 $459,000
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $32,358 - $36,285	523 Added 9.43%	6,070 $410,000
Q1 2019 May 09, 2019	BUY	$62.53 - $70.05 $10,442 - $11,698	167 Added 3.1%	5,547 $361,000
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $539,108 - $703,495	-8,905 Reduced 62.34%	5,380 $337,000
Q3 2018 Oct 12, 2018	SELL	$71.28 - $78.92 $8,910 - $9,865	-125 Reduced 0.87%	14,285 $1.1 Million
Q2 2018 Jul 16, 2018	BUY	$64.88 - $75.68 $4,022 - $4,692	62 Added 0.43%	14,410 $1.02 Million
Q1 2018 Apr 06, 2018	BUY	$72.84 - $88.8 $19,448 - $23,709	267 Added 1.9%	14,348 $1.08 Million
Q4 2017 Jan 24, 2018	SELL	$71.15 - $83.52 $9,961 - $11,692	-140 Reduced 0.98%	14,081 $1.01 Million
Q3 2017 Oct 24, 2017	BUY	$72.11 - $85.47 $1.03 Million - $1.22 Million	14,221	14,221 $1.15 Million

Others Institutions Holding GILD

# of Institutions

1,895

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Account

Rathbones Group PLC Gilead Sciences, Inc. Transaction History